| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The Lancet 396 (10258), 1223-1249, 2020 | 5389 | 2020 |
| Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 E Nichols, JD Steinmetz, SE Vollset, K Fukutaki, J Chalek, F Abd-Allah, ... The Lancet Public Health 7 (2), e105-e125, 2022 | 1766 | 2022 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1175 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 568 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 528 | 2020 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 304 | 2021 |
| Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ... Injury Prevention 26 (Suppl 2), i96-i114, 2020 | 273 | 2020 |
| Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ... Injury Prevention 26 (Suppl 2), i96-i114, 2020 | 273 | 2020 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 215 | 2022 |
| Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ... Injury Prevention 26 (Suppl 2), i125-i153, 2020 | 156 | 2020 |
| Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 JL Ward, PS Azzopardi, KL Francis, JS Santelli, V Skirbekk, SM Sawyer, ... The Lancet 398 (10311), 1593-1618, 2021 | 122 | 2021 |
| Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’packages containing synthetic cathinones AM Araújo, MJ Valente, M Carvalho, D Dias da Silva, H Gaspar, ... Archives of Toxicology 89, 757-771, 2015 | 119 | 2015 |
| The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 G Castelpietra, AKS Knudsen, EE Agardh, B Armocida, M Beghi, KM Iburg, ... The Lancet Regional Health–Europe 16, 2022 | 117 | 2022 |
| Pharmacokinetic and pharmacodynamic aspects of peyote and mescaline: clinical and forensic repercussions RJ Dinis-Oliveira, CL Pereira, DD da Silva Current molecular pharmacology 12 (3), 184-194, 2019 | 83 | 2019 |
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 B Armocida, L Monasta, S Sawyer, F Bustreo, G Segafredo, ... The Lancet Child & Adolescent Health 6 (6), 367-383, 2022 | 80 | 2022 |
| Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N, N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact AM Brito-da-Costa, D Dias-da-Silva, NGM Gomes, RJ Dinis-Oliveira, ... Pharmaceuticals 13 (11), 334, 2020 | 78 | 2020 |
| Combination effects of amphetamines under hyperthermia‐the role played by oxidative stress DD Da Silva, E Silva, H Carmo Journal of Applied Toxicology 34 (6), 637-650, 2014 | 77 | 2014 |
| An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis D Dias da Silva, H Carmo, A Lynch, E Silva Archives of toxicology 87, 2165-2185, 2013 | 68 | 2013 |
| Protective ability against oxidative stress of brewers’ spent grain protein hydrolysates EF Vieira, DD da Silva, H Carmo, IM Ferreira Food chemistry 228, 602-609, 2017 | 66 | 2017 |
| Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment MD Arbo, R Silva, DJ Barbosa, DD da Silva, LG Rossato, ... Toxicology letters 229 (1), 178-189, 2014 | 56 | 2014 |
